InsiderClue
← All stocks

Dianthus Therapeutics, Inc. /DE/

DNTH Scheduled selling only
CIK 0001690585 #1220 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$71.20M
$0.00 on a plan · $71.20M straight out of an exercise
Sold at will
$0.00
0 of 66 sales
Net
−$71.20M
$0.00 against sales at will

By person

9 insiders · 69 transactions
10.8×

Marino Garcia holds 10.8 times base salary in stock. $6.82M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marino Garcia last reported holding, valued at $104.39, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Garcia Marino
CEO AND PRESIDENT
—
$27.96M (12) scheduled
−$27.96M
65,292
0.1167%
$6.82M
—
Randhawa Simrat
EVP, Head of R&D
—
$15.00M (11) scheduled
−$15.00M
4,000
0.0072%
$417.56K
0.0%
Savitz Ryan
EVP, CFO & CBO
—
$14.29M (13) scheduled
−$14.29M
0
0.0000%
$0.00
—
CARR EDWARD
CHIEF ACCOUNTING OFFICER
—
$5.59M (10) scheduled
−$5.59M
0
0.0000%
$0.00
—
Veness Adam M
SVP, General Counsel and Sec.
—
$4.63M (5) scheduled
−$4.63M
15,000
0.0268%
$1.57M
—
Soteropoulos Paula
Director
—
$2.25M (3) scheduled
−$2.25M
0
0.0000%
$0.00
—
McGeorge Anne
Director
—
$844.82K (5) scheduled
−$844.82K
0
0.0000%
$0.00
—
Read Simon
Director
—
$630.79K (7) scheduled
−$630.79K
0
0.0000%
$0.00
—
Fairmount Funds Management LLC entity
Director
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

69
Insider
Date
Role
Action
Shares
Price
Amount
CARR EDWARD
17 Sep 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
700
$104.39
$73.07K
CARR EDWARD
17 Sep 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
1,100
$103.20
$113.52K
CARR EDWARD
17 Sep 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
3,501
$102.39
$358.47K
CARR EDWARD
17 Sep 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
6,771
$101.37
$686.38K
CARR EDWARD
17 Sep 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
7,928
$100.43
$796.21K
Randhawa Simrat
1 Sep 2026
EVP, Head of R&D
Sold after exercise
13,309
$106.74
$1.42M
Randhawa Simrat
1 Sep 2026
EVP, Head of R&D
Sold after exercise
7,215
$106.25
$766.59K
Randhawa Simrat
1 Sep 2026
EVP, Head of R&D
Sold after exercise
2,600
$105.19
$273.49K
Read Simon
19 Aug 2026
Director
Sold after exercise
2,778
$117.55
$326.55K
Veness Adam M
13 Aug 2026
SVP, General Counsel and Sec.
Exercised, kept
15,000
$18.17
$272.55K
Veness Adam M
10 Aug 2026
SVP, General Counsel and Sec.
Sold after exercise
16,167
$110.38
$1.78M
Read Simon
10 Aug 2026
Director
Sold after exercise
397
$111.77
$44.37K
Read Simon
10 Aug 2026
Director
Sold after exercise
470
$111.05
$52.19K
Read Simon
10 Aug 2026
Director
Sold after exercise
272
$109.96
$29.91K
Read Simon
10 Aug 2026
Director
Sold after exercise
831
$108.95
$90.54K
Read Simon
10 Aug 2026
Director
Sold after exercise
737
$108.17
$79.72K
Read Simon
10 Aug 2026
Director
Sold after exercise
70
$107.11
$7.50K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
700
$111.41
$77.99K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
1,000
$110.64
$110.64K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
1,800
$109.30
$196.74K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
2,800
$108.38
$303.46K
McGeorge Anne
10 Aug 2026
Director
Sold after exercise
1,450
$107.58
$155.99K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
21,909
$108.72
$2.38M
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
104,091
$107.96
$11.24M
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
800
$110.76
$88.61K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
2,536
$110.02
$279.01K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
2,373
$109.10
$258.89K
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
23,907
$108.05
$2.58M
Garcia Marino
7 Aug 2026
CEO AND PRESIDENT
Sold after exercise
10,384
$107.49
$1.12M
Veness Adam M
7 Aug 2026
SVP, General Counsel and Sec.
Sold after exercise
616
$111.18
$68.49K
Veness Adam M
7 Aug 2026
SVP, General Counsel and Sec.
Sold after exercise
3,217
$110.61
$355.83K
Savitz Ryan
9 Jul 2026
EVP, CFO & CBO
Sold after exercise
5,566
$101.97
$567.57K
Savitz Ryan
9 Jul 2026
EVP, CFO & CBO
Sold after exercise
15,329
$101.24
$1.55M
Savitz Ryan
9 Jul 2026
EVP, CFO & CBO
Sold after exercise
10,354
$100.22
$1.04M
Veness Adam M
17 Jun 2026
SVP, General Counsel and Sec.
Sold after exercise
13,229
$81.38
$1.08M
Veness Adam M
17 Jun 2026
SVP, General Counsel and Sec.
Sold after exercise
16,771
$80.34
$1.35M
Randhawa Simrat
1 Jun 2026
EVP, Head of R&D
Sold after exercise
4,159
$91.37
$380.01K
Randhawa Simrat
1 Jun 2026
EVP, Head of R&D
Sold after exercise
16,943
$90.72
$1.54M
Randhawa Simrat
1 Jun 2026
EVP, Head of R&D
Sold after exercise
5,428
$89.72
$487.00K
Soteropoulos Paula
8 May 2026
Director
Sold after exercise
599
$85.47
$51.20K
Savitz Ryan
9 Apr 2026
EVP, CFO & CBO
Sold after exercise
8,224
$89.84
$738.84K
Soteropoulos Paula
31 Mar 2026
Director
Sold after exercise
599
$80.11
$47.99K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
7,232
$85.54
$618.63K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
19,469
$84.57
$1.65M
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
59,800
$83.90
$5.02M
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
2,366
$82.84
$196.00K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
800
$81.36
$65.09K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
1,485
$80.25
$119.17K
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
21,825
$78.86
$1.72M
Savitz Ryan
31 Mar 2026
EVP, CFO & CBO
Sold after exercise
1,390
$78.33
$108.88K
Soteropoulos Paula
24 Mar 2026
Director
Sold after exercise
27,594
$78.05
$2.15M
Garcia Marino
16 Mar 2026
CEO AND PRESIDENT
Exercised, kept
5,592
$17.88
$99.98K
Garcia Marino
16 Mar 2026
CEO AND PRESIDENT
Exercised, kept
59,700
$6.70
$399.99K
Randhawa Simrat
12 Mar 2026
EVP, Head of R&D
Sold after exercise
33,830
$81.48
$2.76M
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
300
$85.53
$25.66K
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
200
$83.38
$16.68K
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
3,865
$82.66
$319.48K
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
23,465
$81.75
$1.92M
CARR EDWARD
12 Mar 2026
CHIEF ACCOUNTING OFFICER
Sold after exercise
15,852
$80.71
$1.28M
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
900
$85.53
$76.98K
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
200
$83.38
$16.68K
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
12,796
$82.60
$1.06M
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
65,517
$81.74
$5.36M
Garcia Marino
12 Mar 2026
CEO AND PRESIDENT
Sold after exercise
43,505
$80.69
$3.51M
Savitz Ryan
4 Dec 2025
CFO & CBO
Sold after exercise
20,000
$45.18
$903.60K
Randhawa Simrat
14 Nov 2025
EVP, Head of R&D
Sold after exercise
109,031
$38.14
$4.16M
Randhawa Simrat
13 Nov 2025
EVP, Head of R&D
Sold after exercise
18,576
$37.72
$700.69K
Randhawa Simrat
13 Nov 2025
EVP, Head of R&D
Sold after exercise
42,765
$37.04
$1.58M
Randhawa Simrat
13 Nov 2025
EVP, Head of R&D
Sold after exercise
26,166
$35.80
$936.74K

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 66
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 978,851
History held since 27 Jun 2018